Hiddo J. L. Heerspink

1. Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
   2019/04/17 by Hiddo J.L. Heerspink, Hiddo J. L. Heerspink, Paul Perco +5 · 32 citations
   Medicine · #Diabetes Treatment and Management #Pancreatic function and diabetes #Chronic Kidney Disease and Diabetes